Enter your terms above and click the 'Search' button.

Showing articles 0 to 14 of 14 Filter Applied: ptosis (Click to remove) Pembrolizumab-Induced Myasthenia Gravis Neurol 91:e1365-e1367, Algaeed, M.,et al, 2018 Myasthenia Gravis NEJM 375:2570-2581, Gilhus, N.E.,et al, 2016 Neurotoxicity of Commonly Used Antineoplastic Agents NEJM 291:75, 1271974., Weiss,H.,et al, 1974 Useful Bedside Testing for Myasthenia Gravis Neurol 94:e1870-e1871, Gomes del Carvalho Neto, E.,et al, 2020 Severe Neurological Toxicity of Immune Checkpoint Inhibitors: Growing Spectrum Ann Neurol 87:659-669, Dubey, D.,et al, 2020 A Child with Arthrogryposis Neurol 91:e995-e998, Irumudomom, O. & Ghosh, P.S., 2018 Immune Checkpoint Inhibitor-Related Myositis and Myocarditis in Patients with Cancer Neurol 91:e985-e994, Touat, M.,et al, 2018 Subarachnoid Hemorrhage Medscape Aug, Becske, T. & Lutsep, H.L., 2016 Cluster Headache BMJ 344:e2407, Nesbitt,A.D.,et al, 2012 Myasthenia Gravis BMJ 345:e8497, Spillane, J.,et al, 2012 Oculopharyngeal Muscular Dystrophy in Hispanic New Mexicans JAMA 286:2437-2440, Becher,M.W.,et al, 2001 Lambert-Eaton Myasthenic Syndrome:Clinical Diagnosis,Immune-Mediated Mechanisms,and Update on Therapies Ann Neurol 37:S63-S73, Sanders,D.B., 1995 Myasthenia Gravis NEJM 330:1797-1810, Drachman,D.B., 1994 Ocular Myasthenia:A Protean Disorder Survey of Ophthalmology 39:169-210, Weinberg,D.A.,et al, 1994 Showing articles 0 to 14 of 14